<DOC>
	<DOCNO>NCT02845180</DOCNO>
	<brief_summary>The purpose study assess local tissue reaction retention adipose allograft extracellular matrix 3 6 month post-injection subcutaneous abdominal tissue healthy volunteer schedule undergo elective panniculectomy .</brief_summary>
	<brief_title>In-Vivo Assessment Adipose Allograft Extracellular Matrix Abdominoplasty Patients</brief_title>
	<detailed_description>This prospective , randomize , two arm , single center study ass adipose tissue development retention implantable allograft adipose matrix ( 'AAM ' ) inject abdominal subcutaneous tissue healthy volunteer undergo elective standard-of-care panniculectomy . This study enroll ten ( 10 ) subject . These subject randomize one two study arm . Arm 1 consist five ( 5 ) subject receive injection AAM follow clinically three ( 3 ) month duration , arm 2 consist five ( 5 ) subject receive injection AAM follow clinically six ( 6 ) month duration . At point completion arm , 3 6 month , inject tissue surgically remove part panniculectomy procedure . Samples AAM inject tissue area surround tissue obtain process histologic evaluation .</detailed_description>
	<criteria>Inclusion Criteria Scheduled undergo elective abdominoplasty . Able provide inform consent . Able understand comply study design willing return research require followup visit . BMI great equal 23 less equal 35 . Thickness subcutaneous tissue abdominal wall least 2cm thick . If female , must test negative urine pregnancy test . If female , must willing utilize acceptable method birth control ( i.e. , oral contraceptive , condom spermicide , etc . ) duration study . Thickness subcutaneous tissue abdominal wall le 2cm thick . Previous liposuction intend sit treatment . Actively take immunosuppressive therapy include systemic steroid ( intranasal/inhaled steroid acceptable ) . Actively receive chemotherapy radiation treatment . Subjects life expectancy le 9 month , terminal condition factor make followup difficult ( e.g . ; fix address , telephone , etc . ) Subjects intolerance additional studyassociated drugs/therapies ( e.g . ; lidocaine , etc. ) . Subjects know coagulopathy . Subjects chronic anticoagulant ( e.g . Coumadin , etc. ) . Subjects pregnant , lactate plan pregnancy study period . Subjects abnormal blood chemistry abnormal laboratory find consider clinically significant would deem subject inappropriate surgical procedure , determine Investigator ( i.e. , CBC Differential , platelet , comprehensive metabolic panel include electrolyte , bun/creatinine , liver function test coagulation test ) . Subjects , determine investigator , history clinical manifestation significant renal , hepatic , cardiovascular , metabolic , neurologic , psychiatric , condition would preclude participation study ( e.g . ; Type I II diabetic patient ) . Subjects know alcohol narcotic drug dependency deem impact compliance . Subjects diagnose autoimmune disorder know affect wound healing , Systemic Lupus Erythematosis ( SLE ) , psoriasis , infection inflammation ( seborrheic dermatitis ) . Subjects currently enrol another investigational study . Study Population Description : Patients schedule undergo elective abdominoplasty Sampling Method : Invitation volunteer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>lipectomy</keyword>
	<keyword>panniculectomy</keyword>
</DOC>